Research Using De-Identified Specimens: A Reminder from FDA | Bass, Berry & Sims PLC

On October 18, the Food and Drug Administration (FDA) issued a letter reminding developers of in vitro diagnostics (IVDs) that institutional review board (IRB) approval is required...

Related Keywords

,Human Services ,Drug Administration ,Berry Sims ,Common Rule ,Subject Protection ,Clinical Studies ,Medical Devices ,Century Cures Act ,